{"ALLE": {"Ticker": "ALLE", "Company": "Allegion", "Sector": "Industrials", "Updated": "2023-01-03", "Rating": [{"Date": "2023-01-03", "Rating": "Upgrade", "Organization": "Vertical Research", "Rating_Change": "Hold to Buy", "Target_Change": "$128"}], "Score": 1.0, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Vertical Research"], "Price_Target": 128.0}, "AAPL": {"Ticker": "AAPL", "Company": "Apple", "Sector": "Information Technology", "Updated": "2023-01-03", "Rating": [{"Date": "2023-01-03", "Rating": "Downgrade", "Organization": "Exane BNP Paribas", "Rating_Change": "Outperform to Neutral", "Target_Change": "$140"}, {"Date": "2022-12-20", "Rating": "Reiterated", "Organization": "JP Morgan", "Rating_Change": "Overweight", "Target_Change": "$200 to $190"}, {"Date": "2022-12-12", "Rating": "Reiterated", "Organization": "Oppenheimer", "Rating_Change": "Outperform", "Target_Change": "$190 to $170"}, {"Date": "2022-10-28", "Rating": "Reiterated", "Organization": "Wedbush", "Rating_Change": "Outperform", "Target_Change": "$220 to $200"}, {"Date": "2022-10-28", "Rating": "Reiterated", "Organization": "Robert W. Baird", "Rating_Change": "Outperform", "Target_Change": "$185 to $170"}, {"Date": "2022-10-28", "Rating": "Reiterated", "Organization": "KeyBanc Capital Markets", "Rating_Change": "Overweight", "Target_Change": "$185 to $177"}, {"Date": "2022-10-28", "Rating": "Reiterated", "Organization": "Deutsche Bank", "Rating_Change": "Buy", "Target_Change": "$175 to $170"}, {"Date": "2022-10-28", "Rating": "Reiterated", "Organization": "DA Davidson", "Rating_Change": "Buy", "Target_Change": "$185 to $167"}, {"Date": "2022-10-28", "Rating": "Reiterated", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$190 to $184"}, {"Date": "2022-10-28", "Rating": "Reiterated", "Organization": "Citigroup", "Rating_Change": "Buy", "Target_Change": "$185 to $175"}, {"Date": "2022-10-28", "Rating": "Reiterated", "Organization": "Barclays", "Rating_Change": "Equal Weight", "Target_Change": "$155 to $156"}, {"Date": "2022-10-17", "Rating": "Reiterated", "Organization": "Morgan Stanley", "Rating_Change": "Overweight", "Target_Change": "$180 to $177"}, {"Date": "2022-10-13", "Rating": "Reiterated", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$201 to $190"}, {"Date": "2022-10-11", "Rating": "Reiterated", "Organization": "Barclays", "Rating_Change": "Equal Weight", "Target_Change": "$169 to $155"}], "Score": 1.43, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 14, "Period": "180 days", "Letter_Rating": "B", "Analists": ["DA Davidson", "Citigroup", "Robert W. Baird", "Wedbush", "Deutsche Bank", "JP Morgan", "Credit Suisse", "Oppenheimer", "Exane BNP Paribas", "KeyBanc Capital Markets", "Barclays", "Morgan Stanley"], "Price_Target": 172.93}, "BAX": {"Ticker": "BAX", "Company": "Baxter International", "Sector": "Health Care", "Updated": "2023-01-03", "Rating": [{"Date": "2023-01-03", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Buy to Neutral", "Target_Change": "$66 to $55"}, {"Date": "2022-12-19", "Rating": "Downgrade", "Organization": "JP Morgan", "Rating_Change": "Overweight to Neutral", "Target_Change": "$68 to $55"}, {"Date": "2022-12-15", "Rating": "Downgrade", "Organization": "Deutsche Bank", "Rating_Change": "Buy to Hold", "Target_Change": "$69 to $51"}, {"Date": "2022-12-12", "Rating": "Downgrade", "Organization": "Citigroup", "Rating_Change": "Buy to Neutral", "Target_Change": "$64 to $58"}, {"Date": "2022-10-18", "Rating": "Initiated", "Organization": "Barclays", "Rating_Change": "Overweight", "Target_Change": "$64"}, {"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Jefferies", "Rating_Change": "Hold", "Target_Change": "$62"}], "Score": -0.5, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 6, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Citigroup", "Deutsche Bank", "JP Morgan", "Jefferies", "BofA Securities", "Barclays"], "Price_Target": 57.5}, "BDX": {"Ticker": "BDX", "Company": "Becton Dickinson", "Sector": "Health Care", "Updated": "2023-01-03", "Rating": [{"Date": "2023-01-03", "Rating": "Upgrade", "Organization": "BofA Securities", "Rating_Change": "Neutral to Buy", "Target_Change": "$250 to $290"}, {"Date": "2022-12-12", "Rating": "Upgrade", "Organization": "Citigroup", "Rating_Change": "Sell to Neutral", "Target_Change": "$221 to $250"}], "Score": 1.5, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "A", "Analists": ["BofA Securities", "Citigroup"], "Price_Target": 270.0}, "COF": {"Ticker": "COF", "Company": "Capital One Financial", "Sector": "Financials", "Updated": "2023-01-03", "Rating": [{"Date": "2023-01-03", "Rating": "Downgrade", "Organization": "Barclays", "Rating_Change": "Overweight to Equal Weight", "Target_Change": "$160 to $119"}, {"Date": "2022-12-01", "Rating": "Downgrade", "Organization": "Morgan Stanley", "Rating_Change": "Equal-Weight to Underweight", "Target_Change": "$115 to $90"}, {"Date": "2022-11-21", "Rating": "Initiated", "Organization": "UBS", "Rating_Change": "Neutral", "Target_Change": "$120"}, {"Date": "2022-11-15", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Buy to Neutral", "Target_Change": "$124 to $113"}], "Score": -1.25, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "D", "Analists": ["UBS", "Barclays", "Morgan Stanley", "BofA Securities"], "Price_Target": 110.5}, "CI": {"Ticker": "CI", "Company": "Cigna", "Sector": "Health Care", "Updated": "2023-01-03", "Rating": [{"Date": "2023-01-03", "Rating": "Downgrade", "Organization": "Wells Fargo", "Rating_Change": "Overweight to Equal Weight", "Target_Change": "$370 to $355"}, {"Date": "2022-11-23", "Rating": "Resumed", "Organization": "Morgan Stanley", "Rating_Change": "Overweight", "Target_Change": "$318 to $347"}, {"Date": "2022-11-21", "Rating": "Downgrade", "Organization": "Raymond James", "Rating_Change": "Strong Buy to Outperform", "Target_Change": "$370"}], "Score": 0.33, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Raymond James", "Morgan Stanley", "Wells Fargo"], "Price_Target": 357.33}, "CFG": {"Ticker": "CFG", "Company": "Citizens Financial Group", "Sector": "Financials", "Updated": "2023-01-03", "Rating": [{"Date": "2023-01-03", "Rating": "Downgrade", "Organization": "Wedbush", "Rating_Change": "Outperform to Neutral", "Target_Change": "$45"}, {"Date": "2022-12-21", "Rating": "Initiated", "Organization": "DA Davidson", "Rating_Change": "Buy", "Target_Change": "$47"}, {"Date": "2022-12-05", "Rating": "Resumed", "Organization": "Morgan Stanley", "Rating_Change": "Overweight", "Target_Change": "$48 to $53"}], "Score": 0.67, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Wedbush", "DA Davidson", "Morgan Stanley"], "Price_Target": 48.33}, "CVS": {"Ticker": "CVS", "Company": "CVS Health", "Sector": "Health Care", "Updated": "2023-01-03", "Rating": [{"Date": "2023-01-03", "Rating": "Downgrade", "Organization": "Evercore ISI", "Rating_Change": "Outperform to In-line", "Target_Change": "$120 to $100"}, {"Date": "2022-11-23", "Rating": "Resumed", "Organization": "Morgan Stanley", "Rating_Change": "Overweight", "Target_Change": "$124 to $119"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Evercore ISI", "Morgan Stanley"], "Price_Target": 109.5}, "EIX": {"Ticker": "EIX", "Company": "Edison International", "Sector": "Utilities", "Updated": "2023-01-03", "Rating": [{"Date": "2023-01-03", "Rating": "Upgrade", "Organization": "UBS", "Rating_Change": "Neutral to Buy", "Target_Change": "$69 to $75"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "A", "Analists": ["UBS"], "Price_Target": 75.0}, "ETR": {"Ticker": "ETR", "Company": "Entergy", "Sector": "Utilities", "Updated": "2023-01-03", "Rating": [{"Date": "2023-01-03", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Buy to Neutral", "Target_Change": "$135 to $119"}], "Score": -1.0, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "D", "Analists": ["BofA Securities"], "Price_Target": 119.0}, "FOXA": {"Ticker": "FOXA", "Company": "Fox Corporation (Class A)", "Sector": "Communication Services", "Updated": "2023-01-03", "Rating": [{"Date": "2023-01-03", "Rating": "Downgrade", "Organization": "Wolfe Research", "Rating_Change": "Peer Perform to Underperform", "Target_Change": "$28"}, {"Date": "2022-10-17", "Rating": "Downgrade", "Organization": "Loop Capital", "Rating_Change": "Buy to Hold", "Target_Change": "$50 to $34"}, {"Date": "2022-10-17", "Rating": "Downgrade", "Organization": "Credit Suisse", "Rating_Change": "Outperform to Neutral", "Target_Change": "$41 to $36"}, {"Date": "2022-10-06", "Rating": "Upgrade", "Organization": "Argus", "Rating_Change": "Hold to Buy", "Target_Change": "$43"}], "Score": -1.0, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Wolfe Research", "Argus", "Credit Suisse", "Loop Capital"], "Price_Target": 35.25}, "GIS": {"Ticker": "GIS", "Company": "General Mills", "Sector": "Consumer Staples", "Updated": "2023-01-03", "Rating": [{"Date": "2023-01-03", "Rating": "Initiated", "Organization": "Wells Fargo", "Rating_Change": "Equal Weight", "Target_Change": ""}, {"Date": "2022-12-06", "Rating": "Downgrade", "Organization": "Deutsche Bank", "Rating_Change": "Buy to Hold", "Target_Change": "$88"}, {"Date": "2022-11-15", "Rating": "Initiated", "Organization": "Exane BNP Paribas", "Rating_Change": "Outperform", "Target_Change": "$90"}], "Score": 0.33, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Deutsche Bank", "Exane BNP Paribas", "Wells Fargo"], "Price_Target": 89.0}, "GILD": {"Ticker": "GILD", "Company": "Gilead Sciences", "Sector": "Health Care", "Updated": "2023-01-03", "Rating": [{"Date": "2023-01-03", "Rating": "Downgrade", "Organization": "RBC Capital Mkts", "Rating_Change": "Outperform to Sector Perform", "Target_Change": "$87"}, {"Date": "2022-12-13", "Rating": "Resumed", "Organization": "BofA Securities", "Rating_Change": "Neutral", "Target_Change": "$85"}, {"Date": "2022-12-09", "Rating": "Downgrade", "Organization": "DZ Bank", "Rating_Change": "Buy to Hold", "Target_Change": "$90"}, {"Date": "2022-10-31", "Rating": "Upgrade", "Organization": "Barclays", "Rating_Change": "Underweight to Equal Weight", "Target_Change": "$60 to $76"}, {"Date": "2022-10-28", "Rating": "Upgrade", "Organization": "Truist", "Rating_Change": "Hold to Buy", "Target_Change": "$76 to $91"}, {"Date": "2022-10-28", "Rating": "Upgrade", "Organization": "Piper Sandler", "Rating_Change": "Neutral to Overweight", "Target_Change": "$79 to $96"}, {"Date": "2022-10-28", "Rating": "Reiterated", "Organization": "Wells Fargo", "Rating_Change": "Equal Weight", "Target_Change": "$74 to $75"}, {"Date": "2022-10-28", "Rating": "Reiterated", "Organization": "RBC Capital Mkts", "Rating_Change": "Outperform", "Target_Change": "$79 to $82"}, {"Date": "2022-10-28", "Rating": "Reiterated", "Organization": "JP Morgan", "Rating_Change": "Overweight", "Target_Change": "$80 to $87"}, {"Date": "2022-10-28", "Rating": "Reiterated", "Organization": "Jefferies", "Rating_Change": "Buy", "Target_Change": "$78 to $86"}, {"Date": "2022-10-28", "Rating": "Reiterated", "Organization": "Cowen", "Rating_Change": "Outperform", "Target_Change": "$75 to $80"}, {"Date": "2022-10-28", "Rating": "Reiterated", "Organization": "BMO Capital Markets", "Rating_Change": "Market Perform", "Target_Change": "$63 to $72"}], "Score": 0.83, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 12, "Period": "180 days", "Letter_Rating": "B", "Analists": ["BMO Capital Markets", "Cowen", "JP Morgan", "Jefferies", "RBC Capital Mkts", "Truist", "Wells Fargo", "BofA Securities", "Barclays", "DZ Bank", "Piper Sandler"], "Price_Target": 83.92}, "PEAK": {"Ticker": "PEAK", "Company": "Healthpeak Properties", "Sector": "Real Estate", "Updated": "2023-01-03", "Rating": [{"Date": "2023-01-03", "Rating": "Upgrade", "Organization": "Jefferies", "Rating_Change": "Hold to Buy", "Target_Change": "$23 to $29"}, {"Date": "2022-12-14", "Rating": "Downgrade", "Organization": "RBC Capital Mkts", "Rating_Change": "Outperform to Sector Perform", "Target_Change": "$35 to $28"}, {"Date": "2022-11-21", "Rating": "Upgrade", "Organization": "Evercore ISI", "Rating_Change": "In-line to Outperform", "Target_Change": "$28"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Evercore ISI", "RBC Capital Mkts", "Jefferies"], "Price_Target": 28.33}, "ITW": {"Ticker": "ITW", "Company": "Illinois Tool Works", "Sector": "Industrials", "Updated": "2023-01-03", "Rating": [{"Date": "2023-01-03", "Rating": "Downgrade", "Organization": "Vertical Research", "Rating_Change": "Buy to Hold", "Target_Change": "$240 to $220"}], "Score": -1.0, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Vertical Research"], "Price_Target": 220.0}, "KEY": {"Ticker": "KEY", "Company": "KeyCorp", "Sector": "Financials", "Updated": "2023-01-03", "Rating": [{"Date": "2023-01-03", "Rating": "Upgrade", "Organization": "Barclays", "Rating_Change": "Underweight to Equal Weight", "Target_Change": "$21 to $24"}, {"Date": "2022-12-21", "Rating": "Initiated", "Organization": "DA Davidson", "Rating_Change": "Buy", "Target_Change": "$20"}, {"Date": "2022-12-13", "Rating": "Downgrade", "Organization": "JP Morgan", "Rating_Change": "Neutral to Underweight", "Target_Change": "$18.50 to $17"}, {"Date": "2022-12-05", "Rating": "Initiated", "Organization": "Morgan Stanley", "Rating_Change": "Equal-Weight", "Target_Change": "$22"}], "Score": 0.75, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Barclays", "DA Davidson", "Morgan Stanley", "JP Morgan"], "Price_Target": 20.75}, "KHC": {"Ticker": "KHC", "Company": "Kraft Heinz", "Sector": "Consumer Staples", "Updated": "2023-01-03", "Rating": [{"Date": "2023-01-03", "Rating": "Initiated", "Organization": "Wells Fargo", "Rating_Change": "Equal Weight", "Target_Change": "$43"}, {"Date": "2022-11-15", "Rating": "Initiated", "Organization": "Exane BNP Paribas", "Rating_Change": "Neutral", "Target_Change": "$39"}, {"Date": "2022-10-10", "Rating": "Upgrade", "Organization": "Goldman", "Rating_Change": "Neutral to Buy", "Target_Change": "$43"}], "Score": 0.67, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Goldman", "Exane BNP Paribas", "Wells Fargo"], "Price_Target": 41.67}, "MTB": {"Ticker": "MTB", "Company": "M&T Bank", "Sector": "Financials", "Updated": "2023-01-03", "Rating": [{"Date": "2023-01-03", "Rating": "Upgrade", "Organization": "Wedbush", "Rating_Change": "Neutral to Outperform", "Target_Change": "$170"}, {"Date": "2023-01-03", "Rating": "Downgrade", "Organization": "Barclays", "Rating_Change": "Overweight to Equal Weight", "Target_Change": "$225 to $194"}, {"Date": "2022-12-21", "Rating": "Initiated", "Organization": "DA Davidson", "Rating_Change": "Neutral", "Target_Change": "$160"}, {"Date": "2022-12-07", "Rating": "Downgrade", "Organization": "Keefe Bruyette", "Rating_Change": "Outperform to Mkt Perform", "Target_Change": "$215 to $180"}, {"Date": "2022-12-05", "Rating": "Resumed", "Organization": "Morgan Stanley", "Rating_Change": "Overweight", "Target_Change": "$220 to $235"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 5, "Period": "180 days", "Letter_Rating": "C", "Analists": ["DA Davidson", "Wedbush", "Keefe Bruyette", "Barclays", "Morgan Stanley"], "Price_Target": 187.8}, "TAP": {"Ticker": "TAP", "Company": "Molson Coors Beverage Company", "Sector": "Consumer Staples", "Updated": "2023-01-03", "Rating": [{"Date": "2023-01-03", "Rating": "Downgrade", "Organization": "Wells Fargo", "Rating_Change": "Equal Weight to Underweight", "Target_Change": "$52 to $45"}, {"Date": "2022-12-06", "Rating": "Downgrade", "Organization": "Deutsche Bank", "Rating_Change": "Hold to Sell", "Target_Change": "$50"}, {"Date": "2022-10-11", "Rating": "Initiated", "Organization": "Wedbush", "Rating_Change": "Neutral", "Target_Change": "$50"}], "Score": -1.33, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Wedbush", "Deutsche Bank", "Wells Fargo"], "Price_Target": 48.33}, "MDLZ": {"Ticker": "MDLZ", "Company": "Mondelez International", "Sector": "Consumer Staples", "Updated": "2023-01-03", "Rating": [{"Date": "2023-01-03", "Rating": "Initiated", "Organization": "Wells Fargo", "Rating_Change": "Overweight", "Target_Change": "$75"}, {"Date": "2023-01-03", "Rating": "Downgrade", "Organization": "RBC Capital Mkts", "Rating_Change": "Outperform to Sector Perform", "Target_Change": "$69"}, {"Date": "2022-12-08", "Rating": "Downgrade", "Organization": "UBS", "Rating_Change": "Buy to Neutral", "Target_Change": "$70 to $71"}, {"Date": "2022-11-15", "Rating": "Initiated", "Organization": "Exane BNP Paribas", "Rating_Change": "Neutral", "Target_Change": "$68"}], "Score": -0.25, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "C", "Analists": ["UBS", "RBC Capital Mkts", "Exane BNP Paribas", "Wells Fargo"], "Price_Target": 70.75}, "PYPL": {"Ticker": "PYPL", "Company": "PayPal", "Sector": "Information Technology", "Updated": "2023-01-03", "Rating": [{"Date": "2023-01-03", "Rating": "Upgrade", "Organization": "Truist", "Rating_Change": "Hold to Buy", "Target_Change": "$95"}, {"Date": "2022-12-13", "Rating": "Resumed", "Organization": "Piper Sandler", "Rating_Change": "Neutral", "Target_Change": "$85"}], "Score": 0.5, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Piper Sandler", "Truist"], "Price_Target": 90.0}, "TMUS": {"Ticker": "TMUS", "Company": "T-Mobile US", "Sector": "Communication Services", "Updated": "2023-01-03", "Rating": [{"Date": "2023-01-03", "Rating": "Downgrade", "Organization": "Wolfe Research", "Rating_Change": "Outperform to Peer Perform", "Target_Change": ""}], "Score": -2.0, "Cumulative_Rating": "Significant Underperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "E", "Analists": ["Wolfe Research"], "Price_Target": 0}, "HSY": {"Ticker": "HSY", "Company": "The Hershey Company", "Sector": "Consumer Staples", "Updated": "2023-01-03", "Rating": [{"Date": "2023-01-03", "Rating": "Initiated", "Organization": "Wells Fargo", "Rating_Change": "Underweight", "Target_Change": ""}, {"Date": "2022-12-08", "Rating": "Upgrade", "Organization": "UBS", "Rating_Change": "Neutral to Buy", "Target_Change": "$244 to $269"}, {"Date": "2022-11-15", "Rating": "Initiated", "Organization": "Exane BNP Paribas", "Rating_Change": "Neutral", "Target_Change": "$235"}], "Score": 0.33, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "C", "Analists": ["UBS", "Exane BNP Paribas", "Wells Fargo"], "Price_Target": 252.0}, "USB": {"Ticker": "USB", "Company": "U.S. Bancorp", "Sector": "Financials", "Updated": "2023-01-03", "Rating": [{"Date": "2023-01-03", "Rating": "Upgrade", "Organization": "Barclays", "Rating_Change": "Equal Weight to Overweight", "Target_Change": "$62 to $68"}, {"Date": "2022-12-21", "Rating": "Initiated", "Organization": "DA Davidson", "Rating_Change": "Neutral", "Target_Change": "$47"}, {"Date": "2022-12-13", "Rating": "Upgrade", "Organization": "Keefe Bruyette", "Rating_Change": "Mkt Perform to Outperform", "Target_Change": "$52 to $58"}, {"Date": "2022-12-01", "Rating": "Downgrade", "Organization": "Wolfe Research", "Rating_Change": "Outperform to Peer Perform", "Target_Change": ""}], "Score": 0.25, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Keefe Bruyette", "Barclays", "Wolfe Research", "DA Davidson"], "Price_Target": 57.67}, "UHS": {"Ticker": "UHS", "Company": "Universal Health Services", "Sector": "Health Care", "Updated": "2023-01-03", "Rating": [{"Date": "2023-01-03", "Rating": "Upgrade", "Organization": "Wells Fargo", "Rating_Change": "Underweight to Equal Weight", "Target_Change": "$113 to $154"}, {"Date": "2022-12-16", "Rating": "Upgrade", "Organization": "BofA Securities", "Rating_Change": "Underperform to Neutral", "Target_Change": "$120 to $145"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "A", "Analists": ["BofA Securities", "Wells Fargo"], "Price_Target": 149.5}, "WYNN": {"Ticker": "WYNN", "Company": "Wynn Resorts", "Sector": "Consumer Discretionary", "Updated": "2023-01-03", "Rating": [{"Date": "2023-01-03", "Rating": "Upgrade", "Organization": "Wells Fargo", "Rating_Change": "Equal Weight to Overweight", "Target_Change": "$74 to $101"}, {"Date": "2022-11-28", "Rating": "Upgrade", "Organization": "JP Morgan", "Rating_Change": "Neutral to Overweight", "Target_Change": "$71 to $91"}, {"Date": "2022-11-21", "Rating": "Initiated", "Organization": "Morgan Stanley", "Rating_Change": "Equal-Weight", "Target_Change": "$77"}], "Score": 1.0, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Morgan Stanley", "Wells Fargo", "JP Morgan"], "Price_Target": 89.67}, "ZBH": {"Ticker": "ZBH", "Company": "Zimmer Biomet", "Sector": "Health Care", "Updated": "2023-01-03", "Rating": [{"Date": "2023-01-03", "Rating": "Downgrade", "Organization": "Evercore ISI", "Rating_Change": "Outperform to In-line", "Target_Change": "$130"}, {"Date": "2022-11-23", "Rating": "Upgrade", "Organization": "Wells Fargo", "Rating_Change": "Underweight to Equal Weight", "Target_Change": ""}, {"Date": "2022-10-18", "Rating": "Initiated", "Organization": "Barclays", "Rating_Change": "Underweight", "Target_Change": "$104"}, {"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Jefferies", "Rating_Change": "Underperform", "Target_Change": "$95"}], "Score": -0.5, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Barclays", "Evercore ISI", "Jefferies", "Wells Fargo"], "Price_Target": 109.67}, "ZION": {"Ticker": "ZION", "Company": "Zions Bancorp", "Sector": "Financials", "Updated": "2023-01-03", "Rating": [{"Date": "2023-01-03", "Rating": "Downgrade", "Organization": "Barclays", "Rating_Change": "Equal Weight to Underweight", "Target_Change": "$68 to $59"}, {"Date": "2022-12-21", "Rating": "Upgrade", "Organization": "DA Davidson", "Rating_Change": "Neutral to Buy", "Target_Change": "$56"}, {"Date": "2022-12-05", "Rating": "Initiated", "Organization": "Morgan Stanley", "Rating_Change": "Equal-Weight", "Target_Change": "$65"}, {"Date": "2022-11-03", "Rating": "Downgrade", "Organization": "Wolfe Research", "Rating_Change": "Outperform to Peer Perform", "Target_Change": ""}, {"Date": "2022-10-07", "Rating": "Downgrade", "Organization": "Keefe Bruyette", "Rating_Change": "Outperform to Mkt Perform", "Target_Change": "$77 to $72"}], "Score": -0.8, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 5, "Period": "180 days", "Letter_Rating": "D", "Analists": ["DA Davidson", "Keefe Bruyette", "Wolfe Research", "Barclays", "Morgan Stanley"], "Price_Target": 63.0}}